Sinusitis
📧 Sign up to get email alerts when something new happens for Sinusitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2010-11-25Clinical Trial Update: A Study of Luffa Operculate Nasal Solution 5mg/mL Compared With Saline (NaCl 09%) for the Relief of Nasal Obstruction [Phase 3]
This Phase 3 clinical trial update describes a study comparing Luffa operculate nasal solution 5 mg/mL to saline for relief of nasal obstruc…
-
CLINICAL_TRIALS withdrawal · 2010-09-03Clinical Trial Update: The Effect of Tranexamic Acid on Intraoperative and Post-Operative Bleeding in Functional Endoscopic Sinus Surgery [NA]
A clinical trial evaluating tranexamic acid for reducing intraoperative and postoperative bleeding in functional endoscopic sinus surgery ha…
-
FDA approval · 2010-09-02FDA Approved: ADVIL COLD AND SINUS — Supplemental Application (Haleon US Holdings LLC)
FDA supplemental application for Advil Cold and Sinus (ibuprofen and pseudoephedrine hydrochloride) submitted by Haleon US Holdings LLC. The…
-
FDA approval · 2010-08-31FDA Approved: ADVIL ALLERGY SINUS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Advil Allergy Sinus (chlorpheniramine maleate, ibuprofen, and pseudoephedrine HCl) from Haleon U…
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Home Usability of a Nasal Lavage System in Children
The clinical trial evaluating at-home usability of a nasal lavage system in children has completed. Results were posted in July 2010.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-06-30Clinical Trial Update: The Hemostatic and Hemodynamic Effects of Adrenaline During Endoscopic Sinus Surgery [Phase 3]
This entry reports an update on a Phase 3 trial evaluating adrenaline's hemostatic and hemodynamic effects during endoscopic sinus surgery f…
-
FDA approval · 2010-06-07FDA Approved: CEFUROXIME AXETIL — Original Application (Golden State Medical Supply, Inc.)
FDA approved an original application for cefuroxime axetil from Golden State Medical Supply, Inc. for use as an oral antibiotic (ANDA).
-
FDA approval · 2010-05-27FDA Approved: ADVIL SINUS CONGESTION AND PAIN — Original Application (Haleon US Holdings LLC)
FDA approves Advil Sinus Congestion and Pain as an original application, combining ibuprofen with phenylephrine hydrochloride to provide tem…
-
FDA label_change · 2010-04-27FDA Approved: CEFACLOR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Cefaclor by Teva, updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2010-03-16Clinical Trial Update: Zmax Compared to Augmentin in Sinusitis [Phase 4]
A Phase 4 trial comparing Zmax (azithromycin) to Augmentin for sinusitis has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-24Clinical Trial Update: Clinical Evaluation of the Ethmoid Sinus Spacer [NA]
A clinical trial evaluating the Ethmoid Sinus Spacer for sinusitis and chronic rhinosinusitis was terminated. Results were posted in Februar…
-
CLINICAL_TRIALS trial_result · 2009-12-02Clinical Trial Update: BAY12-8039: 5 Days for Sinusitis vs Placebo [Phase 3]
Phase 3 trial by Bayer comparing BAY12-8039 to placebo for sinusitis has completed; results have been posted.
-
FDA approval · 2009-05-19FDA Approved: ADVIL COLD AND SINUS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Advil Cold and Sinus (ibuprofen and pseudoephedrine hydrochloride) from Haleon US Holdings LLC.
-
FDA approval · 2009-05-19FDA Approved: ADVIL ALLERGY SINUS — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Advil Allergy Sinus, a multi-ingredient combination product from Haleon US Holdings LLC.
-
FDA approval · 2009-05-19FDA Approved: ADVIL COLD AND SINUS — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Advil Cold and Sinus, incorporating ibuprofen with pseudoephedrine hydrochloride to expand l…
-
CLINICAL_TRIALS trial_result · 2009-05-06Clinical Trial Update: Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers [Phase 4]
Phase 4 clinical trial evaluating histamine, CGRP, and VIP as biomarkers for activation of trigeminal and parasympathetic nerve fibers in mi…
-
CLINICAL_TRIALS trial_result · 2009-02-18Clinical Trial Update: Study of the Use of LUMA Lightwire [Phase 4]
The Phase 4 trial of LUMA Lightwire for sinusitis sponsored by Lahey Clinic has been terminated.
-
FDA approval · 2009-02-02FDA Approved: AMOXICILLIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for amoxicillin from Teva Pharmaceuticals USA, Inc., resulting in updated labeling and specification…
-
FDA approval · 2008-09-23FDA Approved: SINUS AND COLD D — Supplemental Application (Meijer Distribution Inc)
FDA approved a supplemental application for Sinus and Cold D, a naproxen sodium and pseudoephedrine hydrochloride combination, distributed b…
-
FDA approval · 2008-06-11FDA Approved: CEFDINIR — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for CEFDINIR (cefdinir) from Lupin Pharmaceuticals, indicating an expanded approval for this antibio…
-
CLINICAL_TRIALS guidance · 2008-05-20Clinical Trial Update: Guidelines for Acute Sinusitis [NA]
Clinical trial update providing guidelines for the management of acute sinusitis; the study is listed as completed.
-
CLINICAL_TRIALS trial_result · 2008-03-17Clinical Trial Update: Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis [Phase 2]
Phase 2 trial update reporting the evaluation of SPRC-AB01 in post-surgical patients with chronic sinusitis; the study status is Completed.
-
FDA approval · 2008-03-10FDA Approved: CEFPROZIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Cefprozil from Teva Pharmaceuticals USA, Inc., updating labeling or indications for the anti…
-
EMA withdrawal · 2008-02-14EMA Withdrawn: Levviax (telithromycin) — Aventis Pharma S.A.
Telithromycin (Levviax) has been withdrawn from the market by Aventis Pharma S.A. for community-acquired infections including pharyngitis, b…
-
FDA approval · 2008-01-16FDA Approved: CEFPROZIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for cefprozil from Lupin Pharmaceuticals, Inc., resulting in updated labeling under the supplemental…